Roth Capital Comments on BioLineRx (BLRX) Following NoA for BL-7010; Sees Additional Milestones Approaching
Tweet Send to a Friend
Roth Capital affirms BioLineRx Ltd. (Nasdaq: BLRX) at Buy with a target price of $8 following news that it received ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
